---
title: Newborn screening for aromatic l-amino acid decarboxylase deficiency - Strategies,
  results, and implication for prevalence calculations
date: '2024-02-01'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38302374/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240202170634&v=2.18.0
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: The proposed screening strategy with 3-OMD detection in
  DBS is feasible and effective to identify individuals with AADCD. The estimated
  birth prevalence supports earlier estimations and confirms AADCD as a very rare
  disorder. Pre-symptomatic identification by NBS allows a disease severity adapted
  drug support to diminish clinical complications until individuals are old enough
  for the application of the gene ...'
disable_comments: true
---
CONCLUSIONS: The proposed screening strategy with 3-OMD detection in DBS is feasible and effective to identify individuals with AADCD. The estimated birth prevalence supports earlier estimations and confirms AADCD as a very rare disorder. Pre-symptomatic identification by NBS allows a disease severity adapted drug support to diminish clinical complications until individuals are old enough for the application of the gene ...